PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer ; volume:15 ; number:1 ; day:13 ; month:3 ; year:2024 ; pages:1-16 ; date:12.2024
Nature Communications ; 15, Heft 1 (13.3.2024), 1-16, 12.2024

Creator
Lin, Chang-Ching
Chang, Tsung-Cheng
Wang, Yunguan
Guo, Lei
Gao, Yunpeng
Bikorimana, Emmanuel
Lemoff, Andrew
Fang, Yisheng V.
Zhang, He
Zhang, Yanfeng
Ye, Dan
Soria-Bretones, Isabel
Servetto, Alberto
Lee, Kyung-min
Luo, Xuemei
Otto, Joseph J.
Akamatsu, Hiroaki
Napolitano, Fabiana
Mani, Ram
Cescon, David W.
Xu, Lin
Xie, Yang
Mendell, Joshua T.
Hanker, Ariella B.
Arteaga, Carlos L.
Contributor
SpringerLink (Online service)

DOI
10.1038/s41467-024-46495-2
URN
urn:nbn:de:101:1-2405152131416.404040201036
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Lin, Chang-Ching
  • Chang, Tsung-Cheng
  • Wang, Yunguan
  • Guo, Lei
  • Gao, Yunpeng
  • Bikorimana, Emmanuel
  • Lemoff, Andrew
  • Fang, Yisheng V.
  • Zhang, He
  • Zhang, Yanfeng
  • Ye, Dan
  • Soria-Bretones, Isabel
  • Servetto, Alberto
  • Lee, Kyung-min
  • Luo, Xuemei
  • Otto, Joseph J.
  • Akamatsu, Hiroaki
  • Napolitano, Fabiana
  • Mani, Ram
  • Cescon, David W.
  • Xu, Lin
  • Xie, Yang
  • Mendell, Joshua T.
  • Hanker, Ariella B.
  • Arteaga, Carlos L.
  • SpringerLink (Online service)

Other Objects (12)